These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 18729007
1. Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agents. Dai DZ, Dai Y. Curr Opin Investig Drugs; 2008 Sep; 9(9):1001-8. PubMed ID: 18729007 [Abstract] [Full Text] [Related]
2. [Ion channels and arrhythmias]. Borchard U, Hafner D. Z Kardiol; 2000 Sep; 89 Suppl 3():6-12. PubMed ID: 10810780 [Abstract] [Full Text] [Related]
3. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization. Cheng JH, Kodama I. Acta Pharmacol Sin; 2004 Feb; 25(2):137-45. PubMed ID: 14769199 [Abstract] [Full Text] [Related]
7. Congenital short QT syndrome. A review. Ginghină C, Ciudin R, Lăpuşanu O, Kulcsar I, Selaru A, Gherasim D. Rom J Intern Med; 2005 Feb; 43(3-4):165-72. PubMed ID: 16812977 [Abstract] [Full Text] [Related]
8. [Current classification of anti-arrhythmia agents]. Weirich J, Wenzel W. Z Kardiol; 2000 Feb; 89 Suppl 3():62-7. PubMed ID: 10810787 [Abstract] [Full Text] [Related]
9. Role of potassium currents in cardiac arrhythmias. Ravens U, Cerbai E. Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669 [Abstract] [Full Text] [Related]
13. Two patterns of ion channelopathy in the myocardium: perspectives for development of anti-arrhythmic agents. Dai DZ. Curr Opin Investig Drugs; 2005 Mar; 6(3):289-97. PubMed ID: 15816506 [Abstract] [Full Text] [Related]
14. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ. Cardiol J; 2008 Mar; 15(3):209-19. PubMed ID: 18651412 [Abstract] [Full Text] [Related]
15. Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents. Drolet B, Simard C, Roden DM. Circulation; 2004 Jan 06; 109(1):26-9. PubMed ID: 14691044 [Abstract] [Full Text] [Related]
16. The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation. Cerrone M, Noujaim S, Jalife J. J Intern Med; 2006 Jan 06; 259(1):24-38. PubMed ID: 16336511 [Abstract] [Full Text] [Related]
17. Plasma CPU-86017 concentrations regarding suppression of ouabain-induced cardiac arrhythmias and decrease of heart rate in guinea pigs. Khan HH, Dai DZ, Xiao DW, Lin S, Wang ZZ, Lou S, Qing Q. Acta Pharmacol Sin; 2000 Nov 06; 21(11):1039-42. PubMed ID: 11501061 [Abstract] [Full Text] [Related]
18. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia]. Semrád B. Vnitr Lek; 2003 Sep 06; 49(9):700-6. PubMed ID: 14584417 [Abstract] [Full Text] [Related]
19. Mechanisms underlying arrhythmogenesis in long QT syndrome. Lankipalli RS, Zhu T, Guo D, Yan GX. J Electrocardiol; 2005 Oct 06; 38(4 Suppl):69-73. PubMed ID: 16226078 [Abstract] [Full Text] [Related]
20. Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy. Dai DZ. Acta Pharmacol Sin; 2000 Apr 06; 21(4):289-95. PubMed ID: 11324452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]